You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
方盛製藥(603998.SH):同系方盛珠海成為湖南珂信單一持股比例最大股東
格隆匯 06-09 16:02

格隆匯6月9日丨方盛製藥(603998.SH)公佈,2020年6月9日,公司接到同系方盛珠海通知,湖南珂信股東之間近日發生了股權轉讓事宜,相關工商變更登記手續已辦理完畢。

寧波梅山保税港區華蓋康滿佳股權投資管理合夥企業(有限合夥)將其持有的湖南珂信的2008.93萬元股權(股權比例為14.0625%)轉讓給北京華蓋信誠遠航醫療產業投資合夥企業(有限合夥);

陳歷宏將其持有的湖南珂信的436.51萬元股權(股權比例為3.0556%)轉讓給華蓋信誠醫療健康投資成都合夥企業(有限合夥);陳歷宏將其持有的湖南珂信的992.06萬元股權(股權比例為6.9444%)轉讓給北京華蓋信誠遠航醫療產業投資合夥企業(有限合夥)。

湖南方盛製藥股份有限公司(以下簡稱“公司”)參與投資設立的同系方盛(珠海)醫藥產業投資合夥企業(有限合夥)(以下簡稱“同系方盛珠海”)參股的湖南珂信健康產業集團有限公司(以下簡稱“湖南珂信”)股東之間發生了股權轉讓交易,但同系方盛珠海所持股份數與持股比例均未發生變動;

湖南珂信此次股東之間股權轉讓導致同系方盛珠海成為湖南珂信單一持股比例最大股東;另,湖南珂美健康產業合夥企業(有限合夥)、湖南珂珂健康產業合夥企業(有限合夥)、湖南珂力達健康產業合夥企業(有限合夥)、湖南珂致賢健康產業合夥企業(有限合夥)等四家合夥企業合計在湖南珂信持有13.37%的股權,鑑於陳歷宏作為前述四家合夥企業最大出資合夥人且擔任執行事務合夥人,因此,陳歷宏合計控制湖南珂信36.68%的股權,仍為湖南珂信控股股東。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account